IP Library Granted Patent US 7,067,697
Granted Patent B2
US 7,067,697 · App. 11/201,496 · Granted Jun 27, 2006

Cationic liposomes for gene transfer

Assignee: Vanderbilt University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,067,697
App. No.
11/201,496
Granted
Jun 27, 2006
Kind
B2
Abstract

The present invention relates to synthetic cationic lipids, liposome formulations and the use of such compounds to introduce functional bioactive agents into cultured cells.

Claims (12)

1. A method for introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising a lipid having the formula:

or a pharmaceutically acceptable salt or ester thereof, wherein R 1 and R 2 are the same and are from C 6 to C 24 alkyl or C 6 to C 24 alkenyl and containing said biologically active agent, whereby said biologically active agent is taken up into said cell.

2. A method for introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with a biologically active agent in the presence of lipid vesicles comprising a lipid having the formula:

or a pharmaceutically acceptable salt or ester thereof, wherein R 1 and R 2 are the same and are from C 6 to C 24 alkyl or C 6 to C 24 alkenyl, whereby said biologically active agent is taken up into said cell.

3. The method according to claim 1 , wherein said biologically active agent is a polynucleotide.

4. The method according to claim 1 , wherein said biologically active agent is DNA or mRNA coding for a polypeptide, and said polypeptide is expressed after said DNA or said mRNA is taken up into said cell.

5. The method according to claim 1 , wherein said contacting step occurs in vitro.

6. The method according to claim 1 , wherein said contacting step occurs in vivo.

7. The method according to claim 2 , wherein said biologically active agent is a polynucleotide.

8. The method according to claim 2 , wherein said biologically active agent is DNA or mRNA coding for a polypeptide, and said polypeptide is expressed after said DNA or said mRNA is taken up into said cell.

9. The method according to claim 2 , wherein said contacting step occurs in vitro.

10. The method according to claim 2 , wherein said contacting step occurs in vivo.

Continuity (5)
Continuation 1022470600 · Aug 20, 2002
Division 0944768800 · Nov 23, 1999
Provisional Application 6010995000 · Nov 25, 1998
Provisional Application 6011097000 · Dec 4, 1998
Related Publication 20060057194A1 · Mar 16, 2006